Skip to main content
Top
Published in: Journal of Gastroenterology 8/2020

01-08-2020 | Metastasis | Original Article—Alimentary Tract

Prevalence and risk factors for lymph node metastasis after noncurative endoscopic resection for early gastric cancer: a systematic review and meta-analysis

Authors: Waku Hatta, Takuji Gotoda, Takeshi Kanno, Yuhong Yuan, Tomoyuki Koike, Paul Moayyedi, Atsushi Masamune

Published in: Journal of Gastroenterology | Issue 8/2020

Login to get access

Abstract

Background

Additional surgery for all patients with noncurative resection after endoscopic resection (ER) for early gastric cancer (EGC) may be excessive due to the relatively low rate of lymph node metastasis (LNM) in such patients. However, the prevalence and risk factors for LNM after noncurative ER have not been consistent across studies.

Methods

We performed a systematic review of electronic databases through August 10, 2018 to identify cohort studies with patients who underwent additional surgery after noncurative ER for EGC. The prevalence of LNM in such patients was extracted for all studies. Odds ratios (ORs) were combined using random-effects meta-analyses to assess the risk of LNM, when possible.

Results

We identified 24 studies comprising 3877 patients with 311 having LNM (pooled prevalence, 8.1%). The risk of LNM was significantly increased in lymphatic invasion (OR [95% confidence interval] = 4.22 [2.88–6.19]), lymphovascular invasion (LVI) (4.17 [2.90–5.99]), vascular invasion (2.38 [1.65–3.44]), positive vertical margin (2.16 [1.59–2.93]), submucosal invasion depth of ≥ 500 μm (2.14 [1.48–3.09]), and tumor size > 30 mm (1.77 [1.31–2.40]). In contrast, there was no significant association between undifferentiated-type or ulceration (scar) and LNM. When studies were restricted to those that evaluated the adjusted OR, the risk of vascular invasion for LNM did not reach statistical significance.

Conclusions

Several pathological factors, most notably lymphatic invasion and LVI, were associated with LNM in patients with noncurative resection after ER for EGC. Lymphatic and vascular invasion should be assessed separately instead of LVI (PROSPERO CRD42018109996).
Appendix
Available only for authorised users
Literature
1.
go back to reference Japanese Gastric Cancer Association. Japanese classification of gastric carcinom: 3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRef Japanese Gastric Cancer Association. Japanese classification of gastric carcinom: 3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRef
2.
go back to reference Japanese Gastric Cancer Association. Gastric cancer treatment guideline. 5th ed. (in Japanese). Tokyo: Kanehara; 2018. Japanese Gastric Cancer Association. Gastric cancer treatment guideline. 5th ed. (in Japanese). Tokyo: Kanehara; 2018.
3.
go back to reference Son SY, Park JY, Ryu KW, et al. The risk factors for lymph node metastasis in early gastric cancer patients who underwent endoscopic resection: is the minimal lymph node dissection applicable? A retrospective study. Surg Endosc. 2013;27:3247–53.PubMedCrossRef Son SY, Park JY, Ryu KW, et al. The risk factors for lymph node metastasis in early gastric cancer patients who underwent endoscopic resection: is the minimal lymph node dissection applicable? A retrospective study. Surg Endosc. 2013;27:3247–53.PubMedCrossRef
4.
go back to reference Hoteya S, Matsui A, Iizuka T, et al. Comparison of the clinicopathological characteristics and results of endoscopic submucosal dissection for esophagogastric junction and non-junctional cancers. Digestion. 2013;87:29–33.PubMedCrossRef Hoteya S, Matsui A, Iizuka T, et al. Comparison of the clinicopathological characteristics and results of endoscopic submucosal dissection for esophagogastric junction and non-junctional cancers. Digestion. 2013;87:29–33.PubMedCrossRef
5.
go back to reference Kawata N, Kakushima N, Takizawa K, et al. Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection. Surg Endosc. 2017;31:1607–16.PubMedCrossRef Kawata N, Kakushima N, Takizawa K, et al. Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection. Surg Endosc. 2017;31:1607–16.PubMedCrossRef
6.
go back to reference Toya Y, Endo M, Nakamura S, et al. Clinical outcomes of non-curative endoscopic submucosal dissection with negative resected margins for gastric cancer. Gastrointest Endosc. 2017;85:1218–24.PubMedCrossRef Toya Y, Endo M, Nakamura S, et al. Clinical outcomes of non-curative endoscopic submucosal dissection with negative resected margins for gastric cancer. Gastrointest Endosc. 2017;85:1218–24.PubMedCrossRef
7.
go back to reference Hatta W, Gotoda T, Oyama T, et al. A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer: "eCura system". Am J Gastroenterol. 2017;112:874–81.PubMedCrossRef Hatta W, Gotoda T, Oyama T, et al. A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer: "eCura system". Am J Gastroenterol. 2017;112:874–81.PubMedCrossRef
8.
go back to reference Kikuchi S, Kuroda S, Nishizaki M, et al. Management of early gastric cancer that meet the indication for radical lymph node dissection following endoscopic resection: a retrospective cohort analysis. BMC Surg. 2017;17:72.PubMedPubMedCentralCrossRef Kikuchi S, Kuroda S, Nishizaki M, et al. Management of early gastric cancer that meet the indication for radical lymph node dissection following endoscopic resection: a retrospective cohort analysis. BMC Surg. 2017;17:72.PubMedPubMedCentralCrossRef
9.
go back to reference Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.PubMedCrossRef Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.PubMedCrossRef
10.
go back to reference Yasunaga H, Horiguchi H, Kuwabara K, et al. Outcomes after laparoscopic or open distal gastrectomy for early-stage gastric cancer: a propensity-matched analysis. Ann Surg. 2013;257:640–6.PubMedCrossRef Yasunaga H, Horiguchi H, Kuwabara K, et al. Outcomes after laparoscopic or open distal gastrectomy for early-stage gastric cancer: a propensity-matched analysis. Ann Surg. 2013;257:640–6.PubMedCrossRef
11.
go back to reference Higuchi N, Nakamura K, Ihara E, et al. Preserved gastric motility in patients with early gastric cancer after endoscopic submucosal dissection. J Gastroenterol Hepatol. 2013;28:494–8.PubMedCrossRef Higuchi N, Nakamura K, Ihara E, et al. Preserved gastric motility in patients with early gastric cancer after endoscopic submucosal dissection. J Gastroenterol Hepatol. 2013;28:494–8.PubMedCrossRef
12.
go back to reference Kikuchi H, Miyata H, Konno H, et al. Development and external validation of preoperative risk models for operative morbidities after total gastrectomy using a Japanese web-based nationwide registry. Gastric Cancer. 2017;20:987–97.PubMedPubMedCentralCrossRef Kikuchi H, Miyata H, Konno H, et al. Development and external validation of preoperative risk models for operative morbidities after total gastrectomy using a Japanese web-based nationwide registry. Gastric Cancer. 2017;20:987–97.PubMedPubMedCentralCrossRef
13.
go back to reference Fukunaga S, Nagami Y, Shiba M, et al. Long-term prognosis of expanded-indication differentiated-type early gastric cancer treated with endoscopic submucosal dissection or surgery using propensity score analysis. Gastrointest Endosc. 2017;85:143–52.PubMedCrossRef Fukunaga S, Nagami Y, Shiba M, et al. Long-term prognosis of expanded-indication differentiated-type early gastric cancer treated with endoscopic submucosal dissection or surgery using propensity score analysis. Gastrointest Endosc. 2017;85:143–52.PubMedCrossRef
14.
go back to reference Toyokawa T, Ohira M, Tanaka H, et al. Optimal management for patients not meeting the inclusion criteria after endoscopic submucosal dissection for gastric cancer. Surg Endosc. 2016;30:2404–14.PubMedCrossRef Toyokawa T, Ohira M, Tanaka H, et al. Optimal management for patients not meeting the inclusion criteria after endoscopic submucosal dissection for gastric cancer. Surg Endosc. 2016;30:2404–14.PubMedCrossRef
15.
go back to reference Suzuki H, Oda I, Abe S, et al. Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series. Gastric Cancer. 2017;20:679–89.PubMedCrossRef Suzuki H, Oda I, Abe S, et al. Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series. Gastric Cancer. 2017;20:679–89.PubMedCrossRef
16.
go back to reference Jung DH, Huh CW, Kim JH, et al. Risk-stratification model based on lymph node metastasis after noncurative endoscopic resection for early gastric cancer. Ann Surg Oncol. 2017;24:1643–9.PubMedCrossRef Jung DH, Huh CW, Kim JH, et al. Risk-stratification model based on lymph node metastasis after noncurative endoscopic resection for early gastric cancer. Ann Surg Oncol. 2017;24:1643–9.PubMedCrossRef
17.
go back to reference Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions [Internet] Version 5.1.0. The Cochrane Collaboration: London, 2011, [updated 2011; accessed August 25, 2018]. Available from www.cochrane-handbook.org. Accessed 25 Aug 2018 Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions [Internet] Version 5.1.0. The Cochrane Collaboration: London, 2011, [updated 2011; accessed August 25, 2018]. Available from www.​cochrane-handbook.​org. Accessed 25 Aug 2018
18.
go back to reference Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.PubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.PubMedPubMedCentral
19.
go back to reference Ono H, Yao K, Fujishiro M, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig Endosc. 2016;28:3–15.PubMedCrossRef Ono H, Yao K, Fujishiro M, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig Endosc. 2016;28:3–15.PubMedCrossRef
20.
go back to reference Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.CrossRef Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.CrossRef
21.
go back to reference Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015;47:829–54.PubMedCrossRef Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015;47:829–54.PubMedCrossRef
22.
go back to reference Munn Z, Moola S, Lisy K, et al. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13:147–53.PubMedCrossRef Munn Z, Moola S, Lisy K, et al. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13:147–53.PubMedCrossRef
24.
go back to reference Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed
25.
26.
go back to reference Easterbrook PJ, Berlin JA, Gopalan R, et al. Publication bias in clinical research. Lancet. 1991;337:867–72.PubMedCrossRef Easterbrook PJ, Berlin JA, Gopalan R, et al. Publication bias in clinical research. Lancet. 1991;337:867–72.PubMedCrossRef
28.
go back to reference Suzuki H, Takizawa K, Hirasawa T, et al. Short-term outcomes of multicenter prospective cohort study of gastric endoscopic resection: 'Real-world evidence' in Japan. Dig Endosc. 2019;31:30–9.PubMedCrossRef Suzuki H, Takizawa K, Hirasawa T, et al. Short-term outcomes of multicenter prospective cohort study of gastric endoscopic resection: 'Real-world evidence' in Japan. Dig Endosc. 2019;31:30–9.PubMedCrossRef
29.
go back to reference Yano T, Ishido K, Tanabe S, et al. Long-term outcomes of patients with early gastric cancer found to have lesions for which endoscopic treatment is not indicated on histopathological evaluation after endoscopic submucosal dissection. Surg Endosc. 2018;32:1314–23.PubMedCrossRef Yano T, Ishido K, Tanabe S, et al. Long-term outcomes of patients with early gastric cancer found to have lesions for which endoscopic treatment is not indicated on histopathological evaluation after endoscopic submucosal dissection. Surg Endosc. 2018;32:1314–23.PubMedCrossRef
30.
go back to reference Sunagawa H, Kinoshita T, Kaito A, et al. Additional surgery for non-curative resection after endoscopic submucosal dissection for gastric cancer: a retrospective analysis of 200 cases. Surg Today. 2017;47:202–9.PubMedCrossRef Sunagawa H, Kinoshita T, Kaito A, et al. Additional surgery for non-curative resection after endoscopic submucosal dissection for gastric cancer: a retrospective analysis of 200 cases. Surg Today. 2017;47:202–9.PubMedCrossRef
31.
go back to reference Goto A, Nishikawa J, Hideura E, et al. Lymph node metastasis can be determined by just tumor depth and lymphovascular invasion in early gastric cancer patients after endoscopic submucosal dissection. Eur J Gastroenterol Hepatol. 2017;29:1346–50.PubMedPubMedCentralCrossRef Goto A, Nishikawa J, Hideura E, et al. Lymph node metastasis can be determined by just tumor depth and lymphovascular invasion in early gastric cancer patients after endoscopic submucosal dissection. Eur J Gastroenterol Hepatol. 2017;29:1346–50.PubMedPubMedCentralCrossRef
32.
go back to reference Nakata B, Tendo M, Okuyama M, et al. Additional surgical resection after endoscopic mucosal dissection for early gastric cancer: a medium-sized hospital's experience. Int J Surg. 2016;36:335–41.PubMedCrossRef Nakata B, Tendo M, Okuyama M, et al. Additional surgical resection after endoscopic mucosal dissection for early gastric cancer: a medium-sized hospital's experience. Int J Surg. 2016;36:335–41.PubMedCrossRef
33.
go back to reference Katsube T, Murayama M, Yamaguchi K, et al. Additional surgery after non-curative resection of ESD for early gastric cancer. Anticancer Res. 2015;35:2969–74.PubMed Katsube T, Murayama M, Yamaguchi K, et al. Additional surgery after non-curative resection of ESD for early gastric cancer. Anticancer Res. 2015;35:2969–74.PubMed
34.
go back to reference Yajima H, Omura N, Takahashi N, et al. Additional gastrectomy after endoscopic mucosal resection for early gastric cancer. Int Surg. 2015;100:169–72.PubMedPubMedCentralCrossRef Yajima H, Omura N, Takahashi N, et al. Additional gastrectomy after endoscopic mucosal resection for early gastric cancer. Int Surg. 2015;100:169–72.PubMedPubMedCentralCrossRef
35.
go back to reference Arigami T, Uenosono Y, Yanagita S, et al. Feasibility of sentinel node navigation surgery after noncurative endoscopic resection for early gastric cancer. J Gastroenterol Hepatol. 2013;28:1343–7.PubMedCrossRef Arigami T, Uenosono Y, Yanagita S, et al. Feasibility of sentinel node navigation surgery after noncurative endoscopic resection for early gastric cancer. J Gastroenterol Hepatol. 2013;28:1343–7.PubMedCrossRef
36.
go back to reference Ito H, Inoue H, Ikeda H, et al. Surgical outcomes and clinicopathological characteristics of patients who underwent potentially noncurative endoscopic resection for gastric cancer: a report of a single-center experience. Gastroenterol Res Pract. 2013;2013:427405.PubMedPubMedCentralCrossRef Ito H, Inoue H, Ikeda H, et al. Surgical outcomes and clinicopathological characteristics of patients who underwent potentially noncurative endoscopic resection for gastric cancer: a report of a single-center experience. Gastroenterol Res Pract. 2013;2013:427405.PubMedPubMedCentralCrossRef
37.
go back to reference Goto O, Fujishiro M, Kakushima N, et al. Endoscopic submucosal dissection as a staging measure may not lead to worse prognosis in early gastric cancer patients with additional gastrectomy. Dig Liver Dis. 2008;40:293–7.PubMedCrossRef Goto O, Fujishiro M, Kakushima N, et al. Endoscopic submucosal dissection as a staging measure may not lead to worse prognosis in early gastric cancer patients with additional gastrectomy. Dig Liver Dis. 2008;40:293–7.PubMedCrossRef
38.
go back to reference Korenaga D, Orita H, Maekawa S, et al. Pathological appearance of the stomach after endoscopic mucosal resection for early gastric cancer. Br J Surg. 1997;84:1563–6.PubMedCrossRef Korenaga D, Orita H, Maekawa S, et al. Pathological appearance of the stomach after endoscopic mucosal resection for early gastric cancer. Br J Surg. 1997;84:1563–6.PubMedCrossRef
39.
go back to reference Kim HS, Ahn JY, Kim SO, et al. Can further gastrectomy be avoided in patients with incomplete endoscopic resection? Surg Endosc. 2017;31:4735–48.PubMedCrossRef Kim HS, Ahn JY, Kim SO, et al. Can further gastrectomy be avoided in patients with incomplete endoscopic resection? Surg Endosc. 2017;31:4735–48.PubMedCrossRef
40.
go back to reference Han JP, Hong SJ, Kim HK, et al. Risk stratification and management of non-curative resection after endoscopic submucosal dissection for early gastric cancer. Surg Endosc. 2016;30:184–9.PubMedCrossRef Han JP, Hong SJ, Kim HK, et al. Risk stratification and management of non-curative resection after endoscopic submucosal dissection for early gastric cancer. Surg Endosc. 2016;30:184–9.PubMedCrossRef
41.
go back to reference Yang HJ, Kim SG, Lim JH, et al. Predictors of lymph node metastasis in patients with non-curative endoscopic resection of early gastric cancer. Surg Endosc. 2015;29:1145–55.PubMedCrossRef Yang HJ, Kim SG, Lim JH, et al. Predictors of lymph node metastasis in patients with non-curative endoscopic resection of early gastric cancer. Surg Endosc. 2015;29:1145–55.PubMedCrossRef
42.
go back to reference Kim ER, Lee H, Min BH, et al. Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer. Br J Surg. 2015;102:1394–401.PubMedCrossRef Kim ER, Lee H, Min BH, et al. Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer. Br J Surg. 2015;102:1394–401.PubMedCrossRef
44.
go back to reference Ryu KW, Choi IJ, Doh YW, et al. Surgical indication for non-curative endoscopic resection in early gastric cancer. Ann Surg Oncol. 2007;14:3428–34.PubMedCrossRef Ryu KW, Choi IJ, Doh YW, et al. Surgical indication for non-curative endoscopic resection in early gastric cancer. Ann Surg Oncol. 2007;14:3428–34.PubMedCrossRef
45.
go back to reference Probst A, Schneider A, Schaller T, et al. Endoscopic submucosal dissection for early gastric cancer: are expanded resection criteria safe for Western patients? Endoscopy. 2017;49:855–65.PubMedCrossRef Probst A, Schneider A, Schaller T, et al. Endoscopic submucosal dissection for early gastric cancer: are expanded resection criteria safe for Western patients? Endoscopy. 2017;49:855–65.PubMedCrossRef
46.
go back to reference Zhao B, Zhang J, Zhang J, et al. Risk factors associated with lymph node metastasis for early gastric cancer patients who underwent non-curative endoscopic resection: a systematic review and meta-analysis. J Gastrointest Surg. 2019;23:1318–28.PubMedCrossRef Zhao B, Zhang J, Zhang J, et al. Risk factors associated with lymph node metastasis for early gastric cancer patients who underwent non-curative endoscopic resection: a systematic review and meta-analysis. J Gastrointest Surg. 2019;23:1318–28.PubMedCrossRef
47.
go back to reference Nie RC, Yuan SQ, Li YF, et al. Additional gastrectomy in early-stage gastric cancer after non-curative endoscopic resection: a meta-analysis. Gastroenterol Rep (Oxf). 2019;7:91–7.CrossRef Nie RC, Yuan SQ, Li YF, et al. Additional gastrectomy in early-stage gastric cancer after non-curative endoscopic resection: a meta-analysis. Gastroenterol Rep (Oxf). 2019;7:91–7.CrossRef
48.
go back to reference Esaki M, Hatta W, Shimosegawa T, et al. Age affects clinical management after noncurative endoscopic submucosal dissection for early gastric cancer. Dig Dis. 2019;37:423–33.PubMedCrossRef Esaki M, Hatta W, Shimosegawa T, et al. Age affects clinical management after noncurative endoscopic submucosal dissection for early gastric cancer. Dig Dis. 2019;37:423–33.PubMedCrossRef
49.
go back to reference Dohi O, Hatta W, Gotoda T, et al. Long-term outcomes after non-curative endoscopic submucosal dissection for early gastric cancer according to hospital volumes in Japan: a multicenter propensity-matched analysis. Surg Endosc. 2019;33:4078–88.PubMedCrossRef Dohi O, Hatta W, Gotoda T, et al. Long-term outcomes after non-curative endoscopic submucosal dissection for early gastric cancer according to hospital volumes in Japan: a multicenter propensity-matched analysis. Surg Endosc. 2019;33:4078–88.PubMedCrossRef
50.
go back to reference Lee SY, Yoshida N, Dohi O, et al. Differences in prevalence of lymphovascular invasion among early gastric cancers between Korea and Japan. Gut Liver. 2017;11:383–91.PubMedPubMedCentralCrossRef Lee SY, Yoshida N, Dohi O, et al. Differences in prevalence of lymphovascular invasion among early gastric cancers between Korea and Japan. Gut Liver. 2017;11:383–91.PubMedPubMedCentralCrossRef
51.
go back to reference Abdelfatah MM, Barakat M, Othman MO, et al. The incidence of lymph node metastasis in submucosal early gastric cancer according to the expanded criteria: a systematic review. Surg Endosc. 2019;33:26–322.PubMedCrossRef Abdelfatah MM, Barakat M, Othman MO, et al. The incidence of lymph node metastasis in submucosal early gastric cancer according to the expanded criteria: a systematic review. Surg Endosc. 2019;33:26–322.PubMedCrossRef
52.
go back to reference Choi AH, Nelson RA, Merchant SJ, et al. Rates of lymph node metastasis and survival in T1a gastric adenocarcinoma in Western populations. Gastrointest Endosc. 2016;83(1184–92):e1. Choi AH, Nelson RA, Merchant SJ, et al. Rates of lymph node metastasis and survival in T1a gastric adenocarcinoma in Western populations. Gastrointest Endosc. 2016;83(1184–92):e1.
53.
54.
go back to reference Sano T, Kobori O, Muto T. Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg. 1992;79:241–4.PubMedCrossRef Sano T, Kobori O, Muto T. Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg. 1992;79:241–4.PubMedCrossRef
55.
go back to reference Hatta W, Gotoda T, Oyama T, et al. Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer? A multi-center retrospective study in Japan. J Gastroenterol. 2017;52:175–84.PubMedCrossRef Hatta W, Gotoda T, Oyama T, et al. Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer? A multi-center retrospective study in Japan. J Gastroenterol. 2017;52:175–84.PubMedCrossRef
Metadata
Title
Prevalence and risk factors for lymph node metastasis after noncurative endoscopic resection for early gastric cancer: a systematic review and meta-analysis
Authors
Waku Hatta
Takuji Gotoda
Takeshi Kanno
Yuhong Yuan
Tomoyuki Koike
Paul Moayyedi
Atsushi Masamune
Publication date
01-08-2020
Publisher
Springer Singapore
Published in
Journal of Gastroenterology / Issue 8/2020
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-020-01685-9

Other articles of this Issue 8/2020

Journal of Gastroenterology 8/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.